2002
DOI: 10.1016/s0169-328x(02)00526-0
|View full text |Cite
|
Sign up to set email alerts
|

Decreased hyperlocomotion induced by MK-801, but not amphetamine and caffeine in mice lacking cellular prion protein (PrPC)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
12
0
1

Year Published

2006
2006
2017
2017

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(13 citation statements)
references
References 36 publications
0
12
0
1
Order By: Relevance
“…For example, reduced excitatory post-synaptic potentials (Carleton et al 2001), impaired formation of long-term potentiation (Collinge et al 1994; Criado et al 2005; Manson et al 1995), reductions in after-hyperpolarization potentials (Mallucci et al 2002, Ratte et al 2002) and abnormal responses to NMDA antagonist MK-801 (Coitinho et al 2002) observed in PrPKO mice all suggest attenuation of L-glutamate-mediated signaling. Many of these alterations would be consistent with the premature termination of the L-glutamate signal and/or the excessive clearance of L-glutamate from the extracellular space surrounding EAA receptors.…”
Section: Discussionmentioning
confidence: 99%
“…For example, reduced excitatory post-synaptic potentials (Carleton et al 2001), impaired formation of long-term potentiation (Collinge et al 1994; Criado et al 2005; Manson et al 1995), reductions in after-hyperpolarization potentials (Mallucci et al 2002, Ratte et al 2002) and abnormal responses to NMDA antagonist MK-801 (Coitinho et al 2002) observed in PrPKO mice all suggest attenuation of L-glutamate-mediated signaling. Many of these alterations would be consistent with the premature termination of the L-glutamate signal and/or the excessive clearance of L-glutamate from the extracellular space surrounding EAA receptors.…”
Section: Discussionmentioning
confidence: 99%
“…The day of the test, mice were injected intraperitoneally with ketamine (30 mg/kg; Sigma-Aldrich), amphetamine (1 mg/kg; Sigma-Aldrich), or saline solution, as control. Drug doses were chosen according to previous reports (for ketamine, Irifune et al, 1991Irifune et al, , 1998Behrens et al, 2007;and for amphetamine, Sansone, 1980;Spielewoy et al, 2001;Coitinho et al, 2002). Behavioral test was performed 30 min and 4 h after injection.…”
Section: Methodsmentioning
confidence: 99%
“…Information on the phenotypes of PrP-knockout mice has been accumulated, and include slight abnormalities such as aberrant circadian rhythms [110][111][112][113], altered locomotion [114][115][116], deficits in spatial learning and memory, and high susceptibility to seizure [117] and brain injury [118,119] in Prnp-knockout mice. Electrophysiological abnormality was also reported [120][121][122][123][124][125][126][127][128][129][130][131], but remains controversial [130][131].…”
Section: Study Of Prp By Gene Targeting Methodsmentioning
confidence: 99%
“…Altered calcium homeostasis ZrchI [144,145] Altered circadian rhythms ZrchI [110][111][112][113] Altered cytokine production and proliferation Rikn, Npu [149,150] Altered locomotion ZrchI [114][115][116] Cellular copper content Rikn, ZrchI, Npu [17,129,143] [164]…”
Section: Study Of Prp By Gene Targeting Methodsmentioning
confidence: 99%